151 related articles for article (PubMed ID: 9533166)
1. The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters.
Nankai M; Klarica M; Fage D; Carter C
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):35-64. PubMed ID: 9533166
[TBL] [Abstract][Full Text] [Related]
2. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds.
Nankai M; Klarica M; Fage D; Carter C
Neurochem Int; 1996 Nov; 29(5):529-42. PubMed ID: 8939463
[TBL] [Abstract][Full Text] [Related]
3. Striatal NMDA receptor subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, gamma-aminobutyric acid, acetylcholine and spermidine release.
Nankai M; Fage D; Carter C
Eur J Pharmacol; 1995 Nov; 286(1):61-70. PubMed ID: 8566152
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of N-methyl-D-aspartate-evoked [3H]noradrenaline release in adult rat spinal cord.
Klarica M; Fage D; Carter C
Eur J Pharmacol; 1996 Jul; 308(2):135-44. PubMed ID: 8840124
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release.
Nankai M; Fage D; Carter C
J Neurochem; 1995 May; 64(5):2043-8. PubMed ID: 7722489
[TBL] [Abstract][Full Text] [Related]
6. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
Hanania T; Johnson KM
Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
[TBL] [Abstract][Full Text] [Related]
7. NMDA receptors with different sensitivities to magnesium and ifenprodil control the release of [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro.
Nicolas C; Fage D; Carter C
J Neurochem; 1994 May; 62(5):1835-9. PubMed ID: 7908945
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA.
Blanchet F; Kemel ML; Gauchy C; Desban M; Perez S; Glowinski J
Neuroscience; 1997 Nov; 81(1):113-27. PubMed ID: 9300405
[TBL] [Abstract][Full Text] [Related]
9. Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition.
Fink K; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):312-9. PubMed ID: 8878061
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
11. Aspartate as a selective NMDA receptor agonist in cultured cells from the avian retina.
Kubrusly RC; de Mello MC; de Mello FG
Neurochem Int; 1998 Jan; 32(1):47-52. PubMed ID: 9460701
[TBL] [Abstract][Full Text] [Related]
12. Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil.
Chizh BA; Reissmüller E; Schlütz H; Scheede M; Haase G; Englberger W
Neuropharmacology; 2001; 40(2):212-20. PubMed ID: 11114400
[TBL] [Abstract][Full Text] [Related]
13. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition.
Pittaluga A; Pattarini R; Feligioni M; Raiteri M
J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986
[TBL] [Abstract][Full Text] [Related]
16. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
17. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
[TBL] [Abstract][Full Text] [Related]
18. Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation.
Blanchet F; Gauchy C; Pérez S; Soubrié P; Glowinski J; Kemel ML
Brain Res; 2000 Jan; 853(1):142-50. PubMed ID: 10627318
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro.
Toner CC; Stamford JA
Eur J Pharmacol; 1997 Dec; 340(2-3):133-43. PubMed ID: 9537807
[TBL] [Abstract][Full Text] [Related]
20. Modulation of striatal dopamine release by glycine transport inhibitors.
Javitt DC; Hashim A; Sershen H
Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
